Trial Profile
A trial comparing the pharmaceutical equivalence of sumatriptan transdermal patches used in a phase III pivotal trial with patches prepared for commercial use in adult volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jun 2011
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors NuPathe
- 10 Jun 2011 New trial record
- 05 Jun 2011 Results presented at the 53rd Annual Scientific Meeting of the American Headache Society.
- 02 Jun 2011 Results will be presented at the 53rd Annual Scientific Meeting of the American Headache Society according to a NuPathe media release.